TGA
Buying group slated over drug ads
A Pharmacy Guild complaint against an advertisement by an online buying group has been upheld by regulators. The TGAs Complaints Resolution Panel has found that international buying group Groupon was …
Bactroban shortage alert
Manufacturing issues lead to shortage of popular impetigo remedy The TGA is advising health professionals and consumers that there is a shortage of Bactroban (mupirocin) 20 mg/g ointment tubes. Bactroban …
Children’s Panadol recall
GlaxoSmithKline is recalling three batches of Children’s Panadol due to possible contamination, the TGA has confirmed. The recall involves two batches of Children’s Panadol 5-12 Suspension Strawberry (200mL) and one …
Meds get new names in TGA alert
The TGA is updating the names of several medicine ingredients to align with names used globally, it reports in today’s Medicines Safety Update. Some medicine ingredient names in Australia have …
Vaccination ad warning
Pharmacists reminded to get their vax service ads right Pharmacies are being reminded that they may only advertise a ‘vaccination service’ to the public and not the actual vaccines themselves. …
Mixed findings from codeine review
A review into the safety and efficacy of OTC codeine-containing medicines reports mixed findings The Australian review concluded that the drugs do provide significant pain relief but with little evidence of …
Vitamin recall
Vitamin batch recalled due to possible incorrect tablet inclusion A single batch of Betamin 100 mg vitamin B1 tablets is being recalled by the TGA, in collaboration with manufacturer Sanofi. …
Epipen warning issued
Regulator warns of safety issues after reports from pharmacies The TGA has issued a safety alert about an EpiPen Adrenaline Auto-injector produced by Alphapharm following reports from pharmacies in a …
In The News
Today in our news roundup: warnings over the timing of TGA staff cuts, and more revelations about big pharma’s business practices No time for cutbacks Revelations that the TGA plans …
Codeine decision by May
Rescheduling review announced by department as May decision date looms A decision on the controversial rescheduling of codeine is expected by May 2016, following a safety review, Department of Health …
ASMI warns consumers against buying CMs from overseas
ASMI says consumers should only purchase complementary medicines approved for supply in Australia because they are highly regulated by the TGA. “Australia’s system of regulating complementary medicines is one of …
Naloxone downschedule will save lives: Angelo Pricolo
The TGA has recommended that naloxone minijet be scheduled to Pharmacist Only medicine—a decision which will likely save lives, says Angelo Pricolo, the Brunswick pharmacist who made the submission. This …